2022 COCA Calls/Webinars Information, Summaries, & Slide Sets
Title: Ebola: Clinical Presentation, Evaluation, and Infection Prevention
Date: Tuesday, December 20, 2022
Presenters:
Mary Choi, MD, MPH
CDR, U.S. Public Health Service
Medical Officer, Viral Special Pathogens Branch
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Trevor Shoemaker, PhD, MPH
Epidemiologist
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Diseases
Centers for Disease Control and Prevention
Amy Valderrama, PhD, RN, FAAN
CAPT, U.S. Public Health Service
Nurse Epidemiologist
Division of Healthcare Quality Promotion
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Brian Harcourt, PhD
CDR, U.S. Public Health Service
Biosafety Officer, Viral Special Pathogens Branch
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Title: COVID-19 Update: Clinical Guidance and Patient Education for Bivalent COVID-19 Vaccines
Date: Tuesday, December 13, 2022
Presenters:
Ruth Link-Gelles, PhD, MPH
LCDR, U.S. Public Health Service
Program Lead, COVID-19 Vaccine Effectiveness
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Lead, Clinical Guidelines, Vaccine Policy Unit
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Richard Quartarone, BA
Acting Communication Team Lead, Immunization Services Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Title: Updates on Multisystem Inflammatory Syndrome in Children (MIS-C): Epidemiology, Case Definition, and COVID-19 Vaccination
Date: Thursday, December 8, 2022
Presenters:
Angela Campbell, MD, MPH, FAAP, FPIDS, FIDSA
Medical Officer
Severe Respiratory Illness and Multisystem Inflammatory Syndrome (SIM) Team Lead
Epidemiology Branch
Coronavirus and Other Respiratory Viruses Division (proposed)
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Michael Melgar, MD
Medical Officer
Severe Respiratory Illness and Multisystem Inflammatory Syndrome (SIM) Team
Epidemiology Branch
Coronavirus and Other Respiratory Viruses Division (proposed)
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Anna Yousaf, MD
Medical Officer
Severe Respiratory Illness and Multisystem Inflammatory Syndrome (SIM) Team
Epidemiology Branch
Coronavirus and Other Respiratory Viruses Division (proposed)
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Title: 2022-2023 Seasonal Influenza Testing and Treatment During the COVID-19 Pandemic
Date: Tuesday, November 15, 2022
Presenters:
Tim Uyeki, MD, MPH, MPP
Chief Medical Officer
Office of the Director
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Title: Update on Monkeypox in Children, Adolescents, and People Who are Pregnant or Breastfeeding
Date: Thursday, October 27, 2022
Presenters:
Romeo R. Galang, MD, MPH
CDC Monkeypox 2022 Multinational Response
Centers for Disease Control and Prevention
Jeremy Gold, MD, MS
CDC Monkeypox 2022 Multinational Response
Centers for Disease Control and Prevention
Anne Kimball, MD, MPH
CDC Monkeypox 2022 Multinational Response
Centers for Disease Control and Prevention
Title: Melioidosis in the United States: What Clinicians Need to Know Following Newly Discovered Endemicity
Date: Thursday, October 13, 2022
Presenters:
Julia Petras, MSPH, BSN, RN
Epidemic Intelligence Service Officer
Bacterial Special Pathogens Branch
Division of High-Consequence Pathogens & Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Caroline A. Schrodt, MD, MSPH
Lieutenant Commander, U.S. Public Health Service
Bacterial Special Pathogens Branch
Division of High-Consequence Pathogens & Pathology
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Title: Update on 2022 Ebola Outbreak in Uganda
Date: Wednesday, October 12, 2022
Presenters:
Trevor Shoemaker, PhD, MPH
Epidemiologist
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Diseases
Centers for Disease Control and Prevention
Mary Choi, MD, MPH
Medical Officer
Division of High-Consequence Pathogens and Pathology
National Center for Emerging and Zoonotic Diseases
Centers for Disease Control and Prevention
Title: Situational Update for Clinicians about Severe Monkeypox Virus Infections
Date: Thursday, October 6, 2022
Presenters:
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Subject Matter Expert, Vaccine Task Force and Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Caroline Schrodt, MD, MSPH
LCDR, U.S. Public Health Service
Lead, Clinical Escalations Team
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Jemma Alarcón, MD, MPH
Los Angeles County Department of Public Health
Epidemic Intelligence Service Officer
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Alexandra Dretler, MD
Adjunct Professor
Infectious Diseases
Emory University
Title: What Clinicians Need to Know about Dengue in the United States
Date: Thursday, September 29, 2022
Presenters:
Laura Adams, DVM, MPH
Epidemiologist
Dengue Branch, Division of Vector-Borne Diseases
Centers for Disease Control and Prevention
Liliana Sánchez-González, MD, MPH
Epidemiologist
Dengue Branch, Division of Vector-Borne Diseases
Centers for Disease Control and Prevention
Title: Evaluating and Supporting Patients Presenting with Cardiovascular Symptoms Following COVID
Date: Tuesday, September 20, 2022
Presenters:
Miriam Nji, MD, MPH
Medical Epidemiologist
Post-COVID Conditions Team
Chronic Viral Diseases Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Jonathan Whiteson, MD, FAAPMR
Medical Director, Cardiac and Pulmonary Rehabilitation
Co-Director, NYU Post COVID Care Program
Rusk Rehabilitation, NYU Langone Health
Alba Azola, MD, FAAPMR
Assistant Professor
Co-director of the Post-Acute COVID-19 Team (JH PACT) Program
Department of Physical Medicine and Rehabilitation
Johns Hopkins University School of Medicine
Title: 2022–2023 Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers
Date: Thursday, September 15, 2022
Presenters:
Fatimah S. Dawood, MD
Medical Officer Epidemiologist
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Kristina A. Bryant, MD, FAAP
Member, AAP Committee on Infectious Diseases
Professor of Pediatrics, University of Louisville School of Medicine
Hospital Epidemiologist at Norton Children’s Hospital
Director for System Pediatric Epidemiology and Infectious Diseases, Norton Children’s Medical Group, Louisville, KY
Title: Recommendations for Bivalent COVID-19 Booster Doses in People Ages 12 Years and Older
Date: Tuesday, September 13, 2022
Presenters:
Sara Oliver, MD, MSPH
CDR, U.S. Public Health Service
Lead, COVID-19 Coordinating Unit
COVID-19 Response
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Evelyn Twentyman, MD, MPH
Lead, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Anne M. Hause, PhD, MSPH
v-safe Team Co-lead, Immunization Safety Office
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Title: 2022-2023 Influenza Vaccination Recommendations and Guidance on Coadministration with COVID-19 Vaccines
Date: Thursday, September 8, 2022
Presenters:
Lisa Grohskopf, MD, MPH
CAPT, U.S. Public Health Service
Medical Officer
Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Evelyn Twentyman, MD, MPH
Lead, Vaccine Policy Unit
COVID-19 Response
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Title: Polio in New York: How to Recognize and Report Polio, and Reinforce Routine Childhood Polio Vaccination
Date: Thursday, September 1, 2022
Presenters:
Farrell Tobolowsky, DO, MS
LCDR, U.S. Public Health Service
Clinical Task Force Lead
2022 NYS Polio Response
Centers for Disease Control and Prevention
Emily Lutterloh, MD, MPH
Director, Division of Epidemiology
New York State Department of Health
Janell Routh, MD, MHS
CAPT, U.S. Public Health Service
Incident Manager
2022 NYS Polio Response
Centers for Disease Control and Prevention
Georgina Peacock, MD, MPH
Director, Division of Immunization Services
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Title: CDC and FDA Update: Interim Clinical Considerations for Monkeypox Vaccination
Date: Thursday, August 11, 2022
Presenters:
Jennifer McQuiston, DVM, MS
CAPT, U.S. Public Health Service
Incident Manager
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Peter Marks, MD, PhD
Director, Center for Biologics Evaluation and Research
U.S. Food & Drug Administration
Elissa Meites, MD, MPH
CAPT, U.S. Public Health Service
Vaccine Team, Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Elisabeth (Liz) Velazquez, RN, BSN, COHN-S
Nurse Educator, Clinical Education Lead
Vaccine Team, Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Title: Recommendations for the Novavax COVID-19 Vaccine Primary Series in Adults Ages 18 Years and Older
Date: Thursday, July 28, 2022
Presenters:
Evelyn Twentyman, MD, MPH
Lead, Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Chris Duggar, MPH
Lead, COVID Vaccine Unit
COVID-19 Response
Centers for Disease Control and Prevention
Tanya Myers, PhD, MSc
Co-Lead, v-safe Team
COVID-19 Immunization Safety Unit
COVID-19 Response
Centers for Disease Control and Prevention
Title: Monkeypox Outbreak: Updates on the Epidemiology, Testing, Treatment, and Vaccination
Date: Tuesday, July 26, 2022
Presenters:
María E. Negrón Sureda, DVM, PhD, MS
Veterinary Medical Officer
Epidemiology Task Force Lead
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Christina L. Hutson PhD, MS
Laboratory and Testing Task Force Lead
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Stephen Flores, PhD
Behavioral Scientist
Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Yon Yu, PharmD
CAPT, U.S. Public Health Service
Regulatory Affairs and Clinical Guidelines Team Lead
Clinical Task Force
2022 Multinational Monkeypox Response
Centers for Disease Control and Prevention
Title: Monkeypox: Updates about Clinical Diagnosis and Treatment
Date: Wednesday, June 29, 2022
Presenters:
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Leandro A. Mena, MD, MPH, FIDSA
Director, Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Centers for Disease Control and Prevention
Brett Petersen, MD, MPH
CAPT, U.S. Public Health Service
Deputy Chief, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Date: Wednesday, June 22, 2022
Presenters:
Sara Oliver, MD, MSPH
CDR, U.S. Public Health Service
Co-lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
Chief Medical Officer, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Clinical Guidelines Lead
Chief Medical Officer, COVID-19 Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Kevin Chatham-Stephens, MD, MPH
CDR, U.S. Public Health Service
Pediatric Vaccine Planning and Implementation Lead
Vaccine Coordination Unit
COVID-19 Response
Centers for Disease Control and Prevention
Anne M. Hause, PhD, MSPH
v-safe Team Co-lead, Immunization Safety Office
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Title: What Clinicians Need to Know About Available Therapeutic Options for COVID-19
Date: Thursday, June 16, 2022
Presenters:
Pragna Patel, MD, MPH
Chief Medical Officer, COVID-19 Response
Centers for Disease Control and Prevention
Eric Daar, MD
Chief, Division of HIV Medicine
Harbor-UCLA Medical Center
Clinical Guidelines Team
National Institutes of Health
John Farley, MD, MPH
Director, Office of Infectious Diseases
Office of New Drugs, Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Meg Sullivan, MD, MPH, FAAP
Chief Medical Officer
Office of the Assistant Secretary for Preparedness and Response
U.S. Department of Health and Human Services
Title: What Clinicians Need to Know about Monkeypox in the United States and Other Countries
Date: Tuesday, May 24, 2022
Presenters:
Agam Rao, MD, FIDSA
CAPT, U.S. Public Health Service
Medical Officer, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Laura Hinkle Bachmann, MD, MPH, FIDSA, FACP
Chief Medical Officer
Division of STD Prevention
National Center for HIV/AIDS, Viral Hepatitis, STD and TB Control
Centers for Disease Control and Prevention
Brett Petersen, MD, MPH
CAPT, U.S. Public Health Service
Deputy Chief, Poxvirus and Rabies Branch
National Center for Emerging and Zoonotic Infectious Diseases
Centers for Disease Control and Prevention
Date: Thursday, May 19, 2022
Presenters:
L. Amanda Ingram, MPH
Epidemiologist Supervisor
Infectious Diseases & Outbreaks Division
Alabama Department of Public Health
Jacqueline Tate, PhD
Epidemiology Team Lead, Viral Gastroenteritis Branch
Division of Viral Diseases
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention
Helena Gutierrez, MD
Medical Director, Pediatric Liver Transplant Program
Assistant Professor, Division of Pediatric Gastroenterology, Hepatology, and Nutrition
The University of Alabama at Birmingham
Elizabeth A. Moulton, MD, PhD
Assistant Professor of Pediatrics
Transplant Infectious Diseases
Baylor College of Medicine
Texas Children’s Hospital
Title: Updated Guidance for Clinicians on COVID-19 Vaccines
Date: Thursday, May 5, 2022
Presenters:
Jennifer Cope, MD, MPH
Medical Officer
Post-COVID Conditions Team
Epidemiology Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Michelle Haddad, PhD
Director of Post-COVID Neuropsychology Clinic
Director of Inpatient Neuropsychology
Departments of Rehabilitation Medicine & Neurology
Emory University School of Medicine
Jeffrey S. Fine, MD, FAAPMR
Associate Professor and Vice Chair, Rusk Rehabilitation
Dept of Rehabilitation Medicine and Dept of Medicine
NYU Langone Health
Talya K. Fleming, MD
Assistant Professor and Medical Director
JFK Johnson Rehabilitation Institute
Dept of Physical Medicine and Rehabilitation
Hackensack Meridian Medicine
Title: Updated Guidance for Clinicians on COVID-19 Vaccines
Date: Thursday, February 24, 2022
Presenters:
Sara Oliver, MD MSPH
LCDR, U.S. Public Health Service
Lead, Advisory Committee for Immunization Practices COVID-19 Vaccines Work Group
COVID-19 Response
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Evelyn Twentyman, MD, MPH
Chief Medical Officer, Vaccine Task Force
COVID-19 Response
Centers for Disease Control and Prevention
Title: COVID-19 Updates: What Clinicians Need to Know About Multisystem Inflammatory Syndrome in Children
Date: Thursday, February 10, 2022
Presenters:
Angela Campbell, MD, MPH, FAAP, FPIDS, FIDSA
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention
Shana Godfred-Cato, DO, FAAP
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention
Anna Yousaf, MD
Medical Officer
Multisystem Inflammatory Syndrome (MIS) Unit
COVID-19 Response
Centers for Disease Control and Prevention
Date: Thursday, January 13, 2022
Presenters:
Lauri Hicks, DO
Captain, U.S. Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Alexander Kallen, MD, MPH
Chief, Prevention and Response Branch
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Pragna Patel, MD, MPH
Deputy Principal Incident Manager, COVID-19 Response
Senior Medical and Science Advisor, HIV Prevention Branch
Division of Global HIV and TB
Centers for Disease Control and Prevention
Title: What Clinicians Need to Know About the New Oral Antiviral Medications for COVID-19
Date: Wednesday, January 12, 2022
Presenters:
Lauri Hicks, DO
Captain, US Public Health Service
Chief Medical Officer, COVID-19 Response
Director, Office of Antibiotic Stewardship
Division of Healthcare Quality Promotion
Centers for Disease Control and Prevention
Colin Shepard, MD
CDC Liaison to the Assistant Secretary for Preparedness and Response (ASPR)
Center for Preparedness and Response
Centers for Disease Control and Prevention
Stephanie Troy, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Aimee Hodowanec, MD
Senior Medical Officer
Division of Antivirals
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Alice K. Pau, PharmD
Executive Secretary, NIH COVID-19 Treatment Guidelines Panel
Staff Scientist (Clinical)
Clinical Pharmacy Specialist
Division of Clinical Research
National Institute of Allergy & Infectious Diseases
National Institutes of Health
Sign up to receive COCA Call Announcements, COCA Newsletters and other COCA resources by entering your email address: